RSS feed (help)
Consultation
We ask for feedback on proposals through public consultation, and take all consultation responses we receive into account before making our decisions.
We welcome feedback from pharmaceutical suppliers, health professionals, health interest groups and the general public. This page includes consultations that are currently underway.
You can respond to consultation by writing to the address at the bottom of the consultation letter.
Rapid response
If you would like to make a rapid response to any of our consultations, 
click here. Remember to indicate which consultation proposal your comments relate to.
Search for previous consultations documents
- Special Authority restrictions for new listings through the tender (3 pages, 43 KB) 01 Jul 2008
- Proposal for Risperdal (risperidone), Topamax (topiramate), Concerta (methylphenidate extended release), Eprex (erythropoietin alpha) and Recormon (erythropoietin beta) - closes 15 July 2008 (5 pages, 310 KB) 25 Jun 2008
- Proposal to remove a number of prescriber & applicant type restrictions in the Blood and Cardiovascular Therapeutic Groups - closes 11 July 2008 (3 pages, 172 KB) 18 Jun 2008
Page updated on 01 Jul 2008
Linked documents
Special Authority restrictions for new listings through the tender (3 pages, 43 KB)
27 June 2008 Proposal for several new listings on the Pharmaceutical Schedule under Special Authority Proposal summary As part of PHARMAC’s annual tender process, PHARMAC is proposing to list several new medicines on the Pharmaceutical Schedule with Special Authority restrictions.…
Proposal for Risperdal (risperidone), Topamax (topiramate), Concerta (methylphenidate extended release), Eprex (erythropoietin alpha) and Recormon (erythropoietin beta) - closes 15 July 2008 (5 pages, 310 KB)
Proposal summary PHARMAC and Janssen-Cilag have reached an agreement that would enable widening of access to several currently funded medicines…
Proposal to remove a number of prescriber & applicant type restrictions in the Blood and Cardiovascular Therapeutic Groups - closes 11 July 2008 (3 pages, 172 KB)
18 June 2008 Proposal to remove a number of prescriber and applicant type restrictions in the Blood and Cardiovascular Therapeutic Groups PHARMAC is seeking feedback on a proposal to amend the funding criteria for a range of products in the…
